IMP: Board Resolution _ March 07, 2019
IMP: Board Resolution _ March 07, 2019
Imexpharm Corporation announces the Board resolution dated March 07, 2019 as follows:
Article 1: Approving the report on business performance in 2018:
- Total revenue in 2018: VND1,207.1 billion, achieving 86.2% plan, increasing 1.8% compared to 2017;
- Profit before tax and before distributing to Science and Technology Fund in 2018: VND192.8 billion, achieving 101.5% plan, increasing 18.6% compared to 2017.
Article 2: Approving the report on progress of two investment projects: (1) Vinh Loc – Binh Tan High-tech Antibiotic Factory; (2) Binh Duong High-tech Factory.
Article 3: Approving business targets for 2019:
- Total revenue in 2018: VND1,450 billion, increasing 20.1% compared to 2018;
- Profit before tax and before distributing to Science and Technology Fund in 2018: VND220 billion, increasing 14.1% compared to 2018.
Article 4: Approving the wage unit, the reward regulation in 2019.
Article 5: Approving the treatment of bad debts with the total value of VND226,040,849.
Article 6: Approving the investment projects: Functional Food Factory and Testing Center in Cao Lanh city, Dong Thap province, as follows:
|
No. |
Project |
Amount (VND) |
|
1 |
Functional Food Factory |
89,000,000,000 |
|
2 |
Testing Center |
31,000,000,000 |
|
|
Total |
120,000,000,000 |
Article 7: Approving the record date for holding the 2019 Annual General Meeting of Shareholders:
- Record date: March 27, 2019
- Meeting date: April 23, 2019
- Meeting venue: Head office of Imexpharm, No.04 Street 30/4, ward 1, Cao Lanh city, Dong Thap province.
Article 8: Approving the agenda of the 2019 Annual General Meeting of Shareholders.
Article 9: Approving the reports and documents for the 2019 Annual General Meeting of Shareholders.
Article 10: Approving to purchase more shares at AGIMEXPHARM Pharmaceutical Joint Stock Company:
- Owning volume of Imexpharm at Agimexpharm: 3,176,116 shares (32.99%)
- Issue ratio for the existing shareholders: 3:1 (those who own 03 shares will be entitled to buy 01 new share)
- Number of shares Imexpharm entitled to buy: 1,058,705 shares
- Estimated issue price: VND10,000/share
- Estimated investment: VND10,587,050,000.
HOSE
